236 related articles for article (PubMed ID: 26235536)
1. Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi).
Thakurdas SM; Lopez MF; Kakuda S; Fernandez-Valdivia R; Zarrin-Khameh N; Haltiwanger RS; Jafar-Nejad H
Hepatology; 2016 Feb; 63(2):550-65. PubMed ID: 26235536
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi.
Fernandez-Valdivia R; Takeuchi H; Samarghandi A; Lopez M; Leonardi J; Haltiwanger RS; Jafar-Nejad H
Development; 2011 May; 138(10):1925-34. PubMed ID: 21490058
[TBL] [Abstract][Full Text] [Related]
3. Bile duct proliferation in Jag1/fringe heterozygous mice identifies candidate modifiers of the Alagille syndrome hepatic phenotype.
Ryan MJ; Bales C; Nelson A; Gonzalez DM; Underkoffler L; Segalov M; Wilson-Rawls J; Cole SE; Moran JL; Russo P; Spinner NB; Kusumi K; Loomes KM
Hepatology; 2008 Dec; 48(6):1989-97. PubMed ID: 19026002
[TBL] [Abstract][Full Text] [Related]
4. A faithful JAGGED1 haploinsufficiency mouse model of arteriohepatic dysplasia (Alagille syndrome) after all.
Huppert SS
Hepatology; 2016 Feb; 63(2):365-7. PubMed ID: 26560881
[No Abstract] [Full Text] [Related]
5. ASO silencing of a glycosyltransferase, Poglut1 , improves the liver phenotypes in mouse models of Alagille syndrome.
Niknejad N; Fox D; Burwinkel JL; Zarrin-Khameh N; Cho S; Soriano A; Cast AE; Lopez MF; Huppert KA; Rigo F; Huppert SS; Jafar-Nejad P; Jafar-Nejad H
Hepatology; 2023 Nov; 78(5):1337-1351. PubMed ID: 37021797
[TBL] [Abstract][Full Text] [Related]
6. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: effects of gene dosage.
Loomes KM; Russo P; Ryan M; Nelson A; Underkoffler L; Glover C; Fu H; Gridley T; Kaestner KH; Oakey RJ
Hepatology; 2007 Feb; 45(2):323-30. PubMed ID: 17366661
[TBL] [Abstract][Full Text] [Related]
7. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome.
Hofmann JJ; Zovein AC; Koh H; Radtke F; Weinmaster G; Iruela-Arispe ML
Development; 2010 Dec; 137(23):4061-72. PubMed ID: 21062863
[TBL] [Abstract][Full Text] [Related]
8. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency.
McCright B; Lozier J; Gridley T
Development; 2002 Feb; 129(4):1075-82. PubMed ID: 11861489
[TBL] [Abstract][Full Text] [Related]
9. Bile Ducts in Regenerative Liver Nodules of Alagille Patients Are Not the Result of Genetic Mosaicism.
Rougemont AL; Alvarez F; McLin VA; Guiochon-Mantel A; Bouligand J; Clément S; Tonson La Tour A; Wildhaber BE; Rubbia-Brandt L; Sartelet H
J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):91-3. PubMed ID: 25643021
[TBL] [Abstract][Full Text] [Related]
10. Microarray data reveal relationship between Jag1 and Ddr1 in mouse liver.
Underkoffler LA; Carr E; Nelson A; Ryan MJ; Schulz R; Loomes KM
PLoS One; 2013; 8(12):e84383. PubMed ID: 24391948
[TBL] [Abstract][Full Text] [Related]
11. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1.
Xue Y; Gao X; Lindsell CE; Norton CR; Chang B; Hicks C; Gendron-Maguire M; Rand EB; Weinmaster G; Gridley T
Hum Mol Genet; 1999 May; 8(5):723-30. PubMed ID: 10196361
[TBL] [Abstract][Full Text] [Related]
12. Human Jagged 1 mutants cause liver defect in Alagille syndrome by overexpression of hepatocyte growth factor.
Yuan ZR; Kobayashi N; Kohsaka T
J Mol Biol; 2006 Feb; 356(3):559-68. PubMed ID: 16403414
[TBL] [Abstract][Full Text] [Related]
13. Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.
Adams JM; Huppert KA; Castro EC; Lopez MF; Niknejad N; Subramanian S; Zarrin-Khameh N; Finegold MJ; Huppert SS; Jafar-Nejad H
Hepatology; 2020 Apr; 71(4):1331-1349. PubMed ID: 31469182
[TBL] [Abstract][Full Text] [Related]
14. Jagged1 (JAG1): Structure, expression, and disease associations.
Grochowski CM; Loomes KM; Spinner NB
Gene; 2016 Jan; 576(1 Pt 3):381-4. PubMed ID: 26548814
[TBL] [Abstract][Full Text] [Related]
15. Genetic background modifies inner ear and eye phenotypes of jag1 heterozygous mice.
Kiernan AE; Li R; Hawes NL; Churchill GA; Gridley T
Genetics; 2007 Sep; 177(1):307-11. PubMed ID: 17890364
[TBL] [Abstract][Full Text] [Related]
16. [From gene to disease: arteriohepatic dysplasia or Alagille syndrome].
Brooks AS; Dooijes D
Ned Tijdschr Geneeskd; 2003 Jun; 147(25):1213-5. PubMed ID: 12848056
[TBL] [Abstract][Full Text] [Related]
17. Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome.
Hofmann JJ; Briot A; Enciso J; Zovein AC; Ren S; Zhang ZW; Radtke F; Simons M; Wang Y; Iruela-Arispe ML
Development; 2012 Dec; 139(23):4449-60. PubMed ID: 23095891
[TBL] [Abstract][Full Text] [Related]
18. JAG1 mutations are found in approximately one third of patients presenting with only one or two clinical features of Alagille syndrome.
Guegan K; Stals K; Day M; Turnpenny P; Ellard S
Clin Genet; 2012 Jul; 82(1):33-40. PubMed ID: 21752016
[TBL] [Abstract][Full Text] [Related]
19. JAG1 Loss-Of-Function Variations as a Novel Predisposing Event in the Pathogenesis of Congenital Thyroid Defects.
de Filippis T; Marelli F; Nebbia G; Porazzi P; Corbetta S; Fugazzola L; Gastaldi R; Vigone MC; Biffanti R; Frizziero D; Mandarà L; Prontera P; Salerno M; Maghnie M; Tiso N; Radetti G; Weber G; Persani L
J Clin Endocrinol Metab; 2016 Mar; 101(3):861-70. PubMed ID: 26760175
[TBL] [Abstract][Full Text] [Related]
20. CCN1 induces hepatic ductular reaction through integrin αvβ₅-mediated activation of NF-κB.
Kim KH; Chen CC; Alpini G; Lau LF
J Clin Invest; 2015 May; 125(5):1886-900. PubMed ID: 25822023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
